SCHEMBL18943085

SCHEMBL18943085

COC(C)(C)N1C(=O)C(F)(F)CC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16844621 0.67 NOTUM (0.33) —
SCHEMBL16844618 0.67 NOTUM (0.33) —
SCHEMBL16844617 0.67 NOTUM (0.33) —
SCHEMBL20388811 0.67 — —
SCHEMBL18943749 0.66 NOTUM (0.32) —
SCHEMBL22025629 0.66 NOTUM (0.32) —
SCHEMBL18943063 0.66 CHRM2 (0.33) —
SCHEMBL22175058 0.66 CHRM2 (0.33) —
SCHEMBL18943251 0.64 PER2 (0.32) —
SCHEMBL20388901 0.57 RIPK1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970234-B1 METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG CAYMAN CHEMICAL CO INC (US) 2018-07-18 — — EP disclosed
EP-3175852-A1 DIFLUOROLACTAM COMPOSITIONS FOR EP4-MEDIATED OSTEO RELATED DISEASES AND CONDITIONS Cayman Chemical Company, Incorporated (US) 2017-06-07 — — EP disclosed
Send feedback